US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.610
  • -0.010-0.22%
Close Dec 13 16:00 ET
  • 4.640
  • +0.030+0.64%
Post 20:01 ET
268.80MMarket Cap-15.90P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vanda Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
49.15M
47.65M
-1.50M
Miss Est.
+26.64%
+22.76%
-3.06%
EPS
-0.16
-0.09
+0.07
Beat Est.
--
-3883.10%
+44.85%
Analyst Rating
Buy

Nov 30, 2024

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.248M--
May 3, 20232023/Q1-- / 62.500M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 52.248M--
May 3, 20232023/Q1-- / 62.500M--
Nov 6, 20242024/Q347.651M / 49.155M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--

Unlock Free Earnings Estimates

Vanda Pharmaceuticals Earnings Reports

  • Vanda Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:13 ET

  • Vanda Pharmaceuticals | 8-K: Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results

    Nov 6 16:22 ET

  • Vanda Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:07 ET

  • Vanda Pharmaceuticals | 8-K: Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results

    Jul 31 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data